N2OFF, Inc.
NITOOther · <br>Emerging growth company · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | — | $210,000 | $263,000 | $394,004 | $438,141 | $232,274 |
| Operating income | −$4.2M | −$4.3M | −$7.6M | −$5.8M | −$4.7M | −$1.3M |
| Net income | −$4.0M | −$5.2M | −$6.5M | −$5.7M | −$4.8M | −$1.6M |
| Total assets | $20.4M | $5.5M | $7.2M | $6.5M | $7.6M | $687,649 |
| Total liabilities | $4.7M | $892,000 | $786,000 | $754,872 | $1.2M | $1.2M |
| Equity | $16.0M | $4.7M | $6.5M | $5.8M | $6.5M | −$436,176 |
| EPS (diluted) | $-8.61 | $-0.89 | $-5.43 | $10.85 | $-2.06 | — |
| Shares out. | 17.8M | 3.0M | 4.7M | 2.8M | 1.6M | 1.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- —
- Return on equity
- −25.0%
- Return on assets
- −19.6%
- Return on capital (ROCE)
- −22.3%
- Liabilities / assets
- 22.9%
- Debt / equity
- 0.29×
- Book value / share
- $0.90
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -2.48distress
- Accruals / assets
- −1.0%clean
- Piotroski F-Score
- 3/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 1 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 17, 2021
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Lee Eun YoungPassive (13G)Mar 23, 2026
- Pierri Ciro LeonardoPassive (13G)Feb 24, 2026
- Silberman AlonPassive (13G)Oct 28, 2025
- Scisparc Ltd.Passive (13G)Oct 24, 2025
- Uziel AmirPassive (13G)May 15, 2025
- Capitalink Ltd.Passive (13G)May 15, 2025
- L.I.A. Pure Capital LtdPassive (13G)May 15, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Lee Eun Young10% owner | Jan 29, 2026 | Sell | 127 | $1.35 |
| Zakai ShlomoOfficer — Controller | Feb 9, 2026 | Grant | 50,000 | $0.00 |
| Barda LitalOfficer — Chief Financial Officer | Feb 9, 2026 | Grant | 50,000 | $0.00 |
| Weiss AmitayDirector | Feb 9, 2026 | Grant | 116,286 | $0.00 |
| Palach DavidOfficer — Chief Executive Officer | Feb 9, 2026 | Grant | 100,000 | $0.00 |
| Barda LitalOfficer — Chief Financial Officer | May 12, 2025 | Grant | 300,000 | $0.00 |
| Palach DavidOfficer — Chief Executive Officer | May 12, 2025 | Grant | 600,000 | $0.00 |
| Rosenbloom RonenDirector | Dec 23, 2024 | Buy | 50,000 | $0.00 |
| Itzhaik AsafDirector | Dec 23, 2024 | Grant | 50,000 | $0.00 |
| Kalifi Udi OvadiaDirector | Dec 23, 2024 | Grant | 50,000 | $0.00 |
| Weiss AmitayDirector | Dec 23, 2024 | Grant | 350,000 | $0.00 |
| Berenstein Israel YakovDirector | Dec 23, 2024 | Grant | 50,000 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| Feb 13, 2026 | 78,161 | 1.0 | -1.5% |
| Jan 30, 2026 | 79,366 | 1.0 | +1471.9% |
| Jan 15, 2026 | 5,049 | 1.0 | +15.0% |
| Dec 31, 2025 | 4,391 | 1.0 | -50.8% |
| Dec 15, 2025 | 8,921 | 1.0 | -58.7% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreement · New financial obligationMay 27, 2026
- Shareholder voteApr 30, 2026
- Modified shareholder rights · Amended charter or bylawsApr 6, 2026
- Completed an acquisition or dispositionMar 17, 2026
- Unregistered equity saleFeb 26, 2026
- Amended charter or bylaws · Regulation FD disclosureFeb 25, 2026
- Entered a material agreement · Unregistered equity saleJan 13, 2026
- Unregistered equity saleJan 12, 2026
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.